These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14177452)

  • 21. [THE ABSENCE OF ANTI-ANAPHYLACTIC ACTIVITY OF EPSILON-AMINOCAPROIC ACID IN THE RAT].
    LECOMTE J; SALMON J; LAMBERT PH
    C R Seances Soc Biol Fil; 1964; 158():1759-61. PubMed ID: 14250635
    [No Abstract]   [Full Text] [Related]  

  • 22. [INFLUENCE OF EPSILON-AMINOCAPROIC ACID ON THE PULMONARY VASCULAR CHANGES FOLLOWING INTRAVENOUS THROMBIN INFUSIONS IN RABBITS].
    STUDER A; LOREZ HP
    Pathol Microbiol (Basel); 1965; 28():425-36. PubMed ID: 14308514
    [No Abstract]   [Full Text] [Related]  

  • 23. PROLONGATION OF CANINE RENAL ALLOGRAFT SURVIVAL BY EPSILON-AMINOCAPROIC ACID, AN IN VITRO INHIBITOR OF COMPLEMENT.
    ZUKOSKI CF; SACHATELLO CR; TINSLEY EA
    Surgery; 1965 Jul; 58():167-73. PubMed ID: 14305151
    [No Abstract]   [Full Text] [Related]  

  • 24. FURTHER STUDIES ON CLOTTING AND FIBRINOLYSIS IN PLASMA FROM THE SMOOTH DOGFISH (MUSTELIS CANIS).
    DOOLITTLE RF
    Br J Haematol; 1963 Oct; 9():464-70. PubMed ID: 14076128
    [No Abstract]   [Full Text] [Related]  

  • 25. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E; SCHMUTZLER R; DUCKERT F
    Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273
    [No Abstract]   [Full Text] [Related]  

  • 26. STUDIES ON THE FIBRINOLYSIS IN TUMOR BEARING MICE. I. FIBRINOLYTIC SYSTEM, ASCITES RETENTION AND INTRAPERITONEAL HEMORRHAGE IN TUMOR BEARING MICE: SUPPRESSING EFFECT OF EPSILON AMINOCAPROIC ACID.
    KINJO K; HIRATA T; OKAMOTO S
    Kobe J Med Sci; 1963 Dec; 18():151-60. PubMed ID: 14160535
    [No Abstract]   [Full Text] [Related]  

  • 27. [ON THE ACTION OF EPSILON-AMINOCAPROIC ACID ON SOME ALLERGIC AND IMMUNOLOGIC PHENOMENA].
    MCFADDEN SW
    Dermatologica; 1965; 130():107-12. PubMed ID: 14302369
    [No Abstract]   [Full Text] [Related]  

  • 28. COMPLEMENT-FIXING ANTIBODIES TO ADENOVIRUS IN RABBITS AND GUINEA-PIGS TREATED WITH 6-MERCAPTOPURINE OR EPSILON-AMINOCAPROIC ACID.
    TOIVANEN P; MAENTYJAERVI R; TOIVANEN A
    Acta Pathol Microbiol Scand; 1965; 63():221-7. PubMed ID: 14295440
    [No Abstract]   [Full Text] [Related]  

  • 29. THE USE OF THE SERIAL THROMBIN TIME IN EVALUATING THERAPY WITH EPSILON AMINOCAPROIC ACID IN MASSIVE THROMBOLYSIS AND PROTEOLYSIS.
    BRODSKY I; ROSS E; REID WO
    Am J Clin Pathol; 1964 Jun; 41():589-96. PubMed ID: 14183048
    [No Abstract]   [Full Text] [Related]  

  • 30. [ON THE INHIBITION OF THE ACTIVIZATION OF PROTEOLYTIC ENZYMES IN RAT PANCREATIC HOMOGENATES AND OF ALPHA-CHYMOTRYPSINOGEN BY EPSILON-AMINOCAPROIC ACID AND P-AMINO-METHYL-BENZOIC ACID].
    TRETTIN HJ
    Z Gesamte Inn Med; 1964 Sep; 19():729-30. PubMed ID: 14232734
    [No Abstract]   [Full Text] [Related]  

  • 31. [EXISTENCE OF CHANGES IN HEMOSTASIS WITH DECREASED FIBRINOLYSIS. BASIS FOR THE HEMOSTATIC TREATMENT WITH EPSILON AMINOCAPROIC ACID IN NON FIBRINOLYTIC HEMORRHAGIC DIATHESIS].
    CASTILLO R; SERRANO J; CARALPS A; VINAS M
    Med Clin (Barc); 1963 Oct; 41():302-6. PubMed ID: 14125259
    [No Abstract]   [Full Text] [Related]  

  • 32. ANTI-FIBRINOLYTIC EFFECT OF EPSILON-AMINOCAPROIC ACID AS MEASURED BY IN VIVO CLOT LYSIS.
    MUTSCHLER LE
    Proc Soc Exp Biol Med; 1964 Apr; 115():1019-24. PubMed ID: 14166549
    [No Abstract]   [Full Text] [Related]  

  • 33. AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSIS.
    SWEENEY WM
    Am J Med Sci; 1965 May; 249():576-89. PubMed ID: 14283294
    [No Abstract]   [Full Text] [Related]  

  • 34. STUDY OF FIBRINOGEN TURNOVER RATES AFTER TOTAL HEPATECTOMY IN DOGS.
    GANS H
    Surgery; 1964 Apr; 55():544-50. PubMed ID: 14138019
    [No Abstract]   [Full Text] [Related]  

  • 35. [COMPARATIVE STUDY ON THE EFFECT OF EPSILON-AMINOCAPROIC ACID, ACETYL-EPSILON-AMINOCAPROIC ACID AND CAPROLACTAM FOR VARIOUS PARAMETERS OF THE FIBRINOLYTIC SYSTEM].
    AUERSWALD W; DOLESCHEL W
    Wien Med Wochenschr; 1965 Feb; 115():102-5. PubMed ID: 14260441
    [No Abstract]   [Full Text] [Related]  

  • 36. [NEW PHARMACOLOGIC PRODUCTS. 3. THE ANTIFIBRINOLYTIC AGENT EPSILON-AMINOCAPROIC ACID].
    STRIEGLER G
    Pharm Prax; 1964; 11():256-8. PubMed ID: 14317099
    [No Abstract]   [Full Text] [Related]  

  • 37. PROLONGED SURVIVAL OF KIDNEY HOMOTRANSPLANTS IN DOG TREATED BY EPSILON-ACETAMIDE CAPROIC ACID.
    BERTELLI A; BISIANI M; CERRINI L; CONFALONIERI A; LIBRO V; LODI E; PROTO M
    Nature; 1964 Jan; 201():209-10. PubMed ID: 14118296
    [No Abstract]   [Full Text] [Related]  

  • 38. [ACTION OF EPSILON AMINOCAPROIC ACID AND ITS ACETYL DERIVATIVE ON BLOOD PROTEINS].
    BONMASSAR E; INGRAMI A; MELAN F; TESTORELLI C
    Folia Allergol (Roma); 1965; 12():108-11. PubMed ID: 14319284
    [No Abstract]   [Full Text] [Related]  

  • 39. THE ROLE OF FIBRINOLYSIN AND PROFIBRINOLYSIN ACTIVATOR IN HEMOPHILIA.
    REID WO; HOLBURN RR; DESIPIN MT; TOCANTINS LM
    Am J Med Sci; 1965 May; 249():518-33. PubMed ID: 14280891
    [No Abstract]   [Full Text] [Related]  

  • 40. ACTIVATION OF COAGULATION AND FIBRINOGEN LOSS AFTER USING AN EXTRACORPOREAL CIRCULATION.
    BLOOM AL
    J Clin Pathol; 1963 Nov; 16(6):558-68. PubMed ID: 14076375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.